Review Reports
- Evgeny S. Ruchko 1,*,
- Zakhar R. Starinnov 1 and
- Andrey V. Vasiliev 1,2
- et al.
Reviewer 1: Anonymous Reviewer 2: Anonymous
Round 1
Reviewer 1 Report
Comments and Suggestions for AuthorsThis manuscript presents a practical and clearly illustrated density-gradient-free workflow for pancreatic islet isolation and subsequent single-cell RNA sequencing. The protocol is well organized, and the workflow diagram and step-by-step images should be useful to researchers working with metabolically vulnerable islets. However, several methodological and reporting issues should be addressed to further improve the reproducibility and assessment of the practical utility of the protocol. Major revision is recommended.
- The claimed time-saving advantage is not fully demonstrated, as the gradient-free workflow still requires 15-30 minutes of manual islet selection per dish. Please provide a clearer comparison of the total processing time and hands-on workload for the two workflows. A simple side-by-side summary would help readers evaluate the practical advantage of the proposed method.
- Total cell number and viability alone may not fully reflect islet-isolation performance. If available, the authors are encouraged to provide the number of islets recovered per pancreas and an estimate of islet purity before dissociation. Capture efficiency should also be reported, given the difference between the number of cells loaded and those ultimately identified. In addition, the lack of direct assessment of islet function should be stated as a limitation.
- The cell numbers reported across the scRNA-seq QC steps are not entirely clear, particularly because the final cell counts appear unchanged after doublet removal. Please clarify the order of the QC steps and report the number of cells retained or removed at each stage. A concise QC table summarizing the main sequencing and filtering metrics for each library would improve transparency and reproducibility.
- The two scRNA-seq libraries were sequenced at substantially different depths, with approximately 87000 reads per cell in the Ficoll library and 47000 reads per cell in the gradient-free library. This difference may affect gene detection and stress-related gene-set scores. A depth-matched down-sampling or sequencing saturation analysis would help ensure a more appropriate comparison between the two libraries.
- Several important protocol details should be reported more clearly, including the dose and route of Avertin, collagenase activity or lot information, preparation of the Ficoll solutions, shaker and rotor specifications, and the dimensions of the wide-bore tips. Reporting these details would further improve reproducibility.
- The raw FASTQ files, raw and filtered expression matrices, cell annotations, mouse-level metadata, and analysis scripts should be deposited in a public repository to improve data transparency and reproducibility.
Author Response
|
Response to Reviewer 1 Comments
|
|||||||||||||||||||||||||||||||||||||||||
|
1. Summary |
|
|
|||||||||||||||||||||||||||||||||||||||
|
We sincerely thank the Reviewer for the careful evaluation of our manuscript and for the constructive comments and suggestions. We have carefully considered all points raised and revised the manuscript accordingly. Detailed responses to each comment are provided below, and the corresponding changes are highlighted in the revised manuscript. We believe that these revisions have improved the clarity, methodological transparency, and overall presentation of the work. |
|||||||||||||||||||||||||||||||||||||||||
|
2. Questions for General Evaluation |
Reviewer’s Evaluation |
Response and Revisions |
|||||||||||||||||||||||||||||||||||||||
|
Does the introduction provide sufficient background and include all relevant references? |
Yes/Can be improved/Must be improved/Not applicable |
|
|||||||||||||||||||||||||||||||||||||||
|
Are all the cited references relevant to the research? |
Yes/Can be improved/Must be improved/Not applicable |
|
|||||||||||||||||||||||||||||||||||||||
|
Is the research design appropriate? |
Yes/Can be improved/Must be improved/Not applicable |
|
|||||||||||||||||||||||||||||||||||||||
|
Are the methods adequately described? |
Yes/Can be improved/Must be improved/Not applicable |
|
|||||||||||||||||||||||||||||||||||||||
|
Are the results clearly presented? |
Yes/Can be improved/Must be improved/Not applicable |
|
|||||||||||||||||||||||||||||||||||||||
|
Are the conclusions supported by the results? |
Yes/Can be improved/Must be improved/Not applicable |
|
|||||||||||||||||||||||||||||||||||||||
|
3. Point-by-point response to Comments and Suggestions for Authors |
|||||||||||||||||||||||||||||||||||||||||
|
Comments 1: The claimed time-saving advantage is not fully demonstrated, as the gradient-free workflow still requires 15-30 minutes of manual islet selection per dish. Please provide a clearer comparison of the total processing time and hands-on workload for the two workflows. A simple side-by-side summary would help readers evaluate the practical advantage of the proposed method. |
|||||||||||||||||||||||||||||||||||||||||
|
Response 1: We thank the reviewer for this comment. We have added a side-by-side comparison of the processing times for the gradient-free and Ficoll-based workflows (Table 4). Importantly, manual islet selection (15–30 min per dish) was performed in both workflows and therefore does not account for the difference in processing time. The gradient-free workflow required an estimated 75–110 min, whereas the Ficoll-based workflow required approximately 110–145 min. The difference results from the Ficoll purification module, which adds approximately 35 min, including 21.5 min of centrifugation and approximately 15 min of Ficoll-specific handling for gradient preparation, interphase collection, dilution, and transfers. We have also revised the text to describe this advantage specifically in terms of the |
|||||||||||||||||||||||||||||||||||||||||
|
Comments 2: Total cell number and viability alone may not fully reflect islet-isolation performance. If available, the authors are encouraged to provide the number of islets recovered per pancreas and an estimate of islet purity before dissociation. Capture efficiency should also be reported, given the difference between the number of cells loaded and those ultimately identified. In addition, the lack of direct assessment of islet function should be stated as a limitation. |
|||||||||||||||||||||||||||||||||||||||||
|
Response 2: We agree that islet yield and pre-dissociation purity would provide useful additional information, but these parameters were not prospectively recorded and cannot be reconstructed reliably. Because mouse islets vary markedly in size and cell content, islet number alone does not directly reflect the amount of material available for scRNA-seq. We therefore focused on viable cell recovery and viability after dissociation, which were the most relevant input measures for library preparation. Capture efficiency was estimated from the recorded loading data. Approximately 24,000 viable cells were loaded for each library, yielding 5,568 initially identified cells in the gradient-free preparation and 4,358 in the Ficoll-based preparation, corresponding to 23.2% and 18.2%, respectively. After QC filtering, 2,659 and 2,715 cells were retained for analysis. These values have now been added to the manuscript. Direct functional testing of the isolated islets, such as glucose-stimulated insulin secretion, was not performed. We therefore cannot draw conclusions about preservation of islet function, and this is now stated as a limitation.
|
|||||||||||||||||||||||||||||||||||||||||
|
Comments 3: The cell numbers reported across the scRNA-seq QC steps are not entirely clear, particularly because the final cell counts appear unchanged after doublet removal. Please clarify the order of the QC steps and report the number of cells retained or removed at each stage. A concise QC table summarizing the main sequencing and filtering metrics for each library would improve transparency and reproducibility. |
|||||||||||||||||||||||||||||||||||||||||
|
Response 3: We thank the reviewer for pointing out that the order of the scRNA-seq QC steps and the reported cell numbers were not sufficiently clear in the previous version. We have revised the Bioinformatic Processing and Cell-Type Annotation section to describe the QC procedure in its sequential order and to distinguish the initially identified cells, cells retained after primary QC, cells remaining after doublet removal, and the final endocrine/exocrine population used for downstream analysis. We have also removed the duplicated reporting of the final cell numbers.
|
|||||||||||||||||||||||||||||||||||||||||
|
Comments 4: The two scRNA-seq libraries were sequenced at substantially different depths, with approximately 87000 reads per cell in the Ficoll library and 47000 reads per cell in the gradient-free library. This difference may affect gene detection and stress-related gene-set scores. A depth-matched down-sampling or sequencing saturation analysis would help ensure a more appropriate comparison between the two libraries. |
|||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||
|
Comments 5: Several important protocol details should be reported more clearly, including the dose and route of Avertin, collagenase activity or lot information, preparation of the Ficoll solutions, shaker and rotor specifications, and the dimensions of the wide-bore tips. Reporting these details would further improve reproducibility. |
|||||||||||||||||||||||||||||||||||||||||
|
Response 5: We thank the reviewer for this suggestion. We have revised the Materials and Methods to provide the requested protocol details. Specifically, we added the dose, concentration, injection volume, and intraperitoneal route of Avertin; collagenase activity and lot information; clarification that the commercial Ficoll solutions were used as supplied and pre-cooled to 4 °C; shaker model, incubation conditions, centrifuge and rotor specifications; and the manufacturer and distal opening diameters of the 1000-µL and 200-µL wide-bore tips. These details have been added throughout the relevant protocol sections to improve reproducibility.
|
|||||||||||||||||||||||||||||||||||||||||
|
Comments 6: The raw FASTQ files, raw and filtered expression matrices, cell annotations, mouse-level metadata, and analysis scripts should be deposited in a public repository to improve data transparency and reproducibility. |
|||||||||||||||||||||||||||||||||||||||||
|
Response 6: We thank the reviewer for this suggestion. The analysis scripts used for scRNA-seq preprocessing, cell-type annotation, and figure generation have been deposited in a public GitHub repository: https://github.com/RuchkoEvgeny/Gradient-Free-Isolation-of-Murine-Pancreatic-Islets-for-Single-Cell-RNA-Sequencing. The raw and processed sequencing data are currently being prepared for deposition in the NCBI Gene Expression Omnibus (GEO). We expect the GEO accession number to become available during September 2026 and will add it to the manuscript as soon as it is assigned. The dataset will be made publicly available prior to publication. The Data Availability Statement has been revised accordingly.
|
|||||||||||||||||||||||||||||||||||||||||
Author Response File:
Author Response.pdf
Reviewer 2 Report
Comments and Suggestions for AuthorsThis manuscript presents a gradient-free workflow for isolation of murine pancreatic islets for subsequent single-cell RNA sequencing. The authors replace Ficoll-based density-gradient purification with stereomicroscope-guided manual islet selection and show that the resulting preparations have high cell viability, retain the major pancreatic endocrine populations, and generate scRNA-seq libraries of acceptable quality. The protocol is potentially useful; however, several claims regarding reduced processing, stress, and reproducibility require clarification or more cautious interpretation.
1. The manuscript should more clearly define whether the gradient-free procedure is intended as an alternative to Ficoll-based density-gradient purification or as a superior/improved method. If superiority is claimed, this would require stronger comparative evidence demonstrating clear advantages in parameters such as overall processing time, cell recovery, viability, reproducibility, and/or preservation of transcriptional state. Otherwise, the current data support presenting the gradient-free workflow as a feasible alternative that produces cells suitable for scRNA-seq.
2. The authors emphasize that the gradient-free protocol eliminates three centrifugation steps and at least 21.5 minutes of centrifuge run time. However, stereomicroscope-guided manual islet selection itself requires substantial hands-on time, reported as 15–30 minutes per dish, and therefore the manuscript should provide total elapsed and hands-on processing times for both workflows before concluding that the new procedure is faster or less time-consuming.
3. Manual islet selection is inherently operator-dependent and may introduce greater person-to-person variability than a standardized density-gradient procedure. The authors should clarify whether isolations were performed by a single operator or multiple operators and, if only one operator was involved, discuss the lack of inter-operator validation as an important limitation of the claimed reproducibility.
4. Relatedly, manual selection may introduce selection bias because operators may preferentially recover larger, more intact, or more easily recognizable islets while excluding less obvious or partially disrupted islets. This could influence islet yield, cell-type composition, and downstream transcriptomic profiles, and the authors should discuss how manual selection criteria were standardized and whether any objective criteria were used.
5. The interpretation that the gradient-free procedure may reduce processing-associated cellular stress should be substantially tempered. Manual microscopic selection, repeated aspiration and transfer, prolonged handling, and time outside optimal physiological conditions may themselves induce mechanical or transcriptional stress, so removal of Ficoll centrifugation cannot by itself be assumed to reduce total cellular stress.
6. The stress-response comparison is particularly limited because the three independently isolated mice were pooled to generate only one scRNA-seq library for each workflow. The authors appropriately acknowledge that these libraries represent single experimental units and that the observed differences cannot be attributed to the isolation method; therefore, statements in the Abstract, Results, and Discussion suggesting reduced stress with the gradient-free protocol should consistently be presented as descriptive observations rather than evidence of a method-specific effect.
7. The Introduction may benefit from briefly acknowledging the broader relevance of pancreatic molecular alterations and emerging molecular biomarkers. In this context, the authors may consider citing the recent review https://doi.org/10.3389/freae.2025.1723159, which provides a useful overview of molecular and epigenetic changes in pancreatic disease and their translational relevance.
8. Because density-gradient purification is a well-established and relatively standardized method, the practical value of replacing it with manual selection would be strengthened by a more comprehensive comparison of the two approaches. In addition to viability and scRNA-seq QC, useful parameters would include total processing time, hands-on time, islet yield, purity, operator-to-operator variability, and reproducibility across independent scRNA-seq libraries; without such comparisons, the gradient-free approach is best presented as a feasible alternative rather than an improved replacement for density-gradient purification.
Author Response
|
Response to Reviewer 2 Comments
|
||||||||||||||||||||||||||||||||||||||||||||
|
1. Summary |
|
|
||||||||||||||||||||||||||||||||||||||||||
|
We are grateful to the Reviewer for the thorough assessment of our manuscript and for the helpful comments and recommendations. Each point has been considered carefully, and the manuscript has been revised accordingly. Our detailed responses are provided below, with the corresponding modifications highlighted in the revised manuscript. We believe that the revised version more clearly defines the scope, limitations, and practical relevance of the study. |
||||||||||||||||||||||||||||||||||||||||||||
|
2. Questions for General Evaluation |
Reviewer’s Evaluation |
Response and Revisions |
||||||||||||||||||||||||||||||||||||||||||
|
Does the introduction provide sufficient background and include all relevant references? |
Yes/Can be improved/Must be improved/Not applicable |
|
||||||||||||||||||||||||||||||||||||||||||
|
Are all the cited references relevant to the research? |
Yes/Can be improved/Must be improved/Not applicable |
|
||||||||||||||||||||||||||||||||||||||||||
|
Is the research design appropriate? |
Yes/Can be improved/Must be improved/Not applicable |
|
||||||||||||||||||||||||||||||||||||||||||
|
Are the methods adequately described? |
Yes/Can be improved/Must be improved/Not applicable |
|
||||||||||||||||||||||||||||||||||||||||||
|
Are the results clearly presented? |
Yes/Can be improved/Must be improved/Not applicable |
|
||||||||||||||||||||||||||||||||||||||||||
|
Are the conclusions supported by the results? |
Yes/Can be improved/Must be improved/Not applicable |
|
||||||||||||||||||||||||||||||||||||||||||
|
3. Point-by-point response to Comments and Suggestions for Authors |
||||||||||||||||||||||||||||||||||||||||||||
|
Comments 1: The manuscript should more clearly define whether the gradient-free procedure is intended as an alternative to Ficoll-based density-gradient purification or as a superior/improved method. If superiority is claimed, this would require stronger comparative evidence demonstrating clear advantages in parameters such as overall processing time, cell recovery, viability, reproducibility, and/or preservation of transcriptional state. Otherwise, the current data support presenting the gradient-free workflow as a feasible alternative that produces cells suitable for scRNA-seq. |
||||||||||||||||||||||||||||||||||||||||||||
|
Response 1: We thank the reviewer for this important comment. We have revised the manuscript throughout to clarify that the gradient-free workflow is presented as a feasible alternative to Ficoll-based purification, not as a superior method. Statements implying improved reproducibility, overall quality, or reduced cellular stress were removed or reformulated. The revised text now focuses on the demonstrated features of the workflow: omission of Ficoll-specific processing steps, recovery of viable cells suitable for scRNA-seq, fulfillment of the applied library QC criteria, and retention of the major endocrine populations. We also explicitly state in the Introduction and Conclusions that the present study was not designed to establish superiority and that stronger comparative evidence with independently prepared matched libraries would be required for such a conclusion.
|
||||||||||||||||||||||||||||||||||||||||||||
|
Comments 2: The authors emphasize that the gradient-free protocol eliminates three centrifugation steps and at least 21.5 minutes of centrifuge run time. However, stereomicroscope-guided manual islet selection itself requires substantial hands-on time, reported as 15–30 minutes per dish, and therefore the manuscript should provide total elapsed and hands-on processing times for both workflows before concluding that the new procedure is faster or less time-consuming. |
||||||||||||||||||||||||||||||||||||||||||||
|
Response 2: We thank the reviewer for this comment. We have added a side-by-side comparison of the processing times for both workflows (Table 4). The revised table shows that manual islet selection required 15–30 min per dish in both workflows and therefore did not contribute to the difference between them. The estimated processing time before the optional fixation steps was 75–110 min for the gradient-free workflow and 110–145 min for the Ficoll-based workflow. The additional time in the Ficoll-based protocol was associated with the purification module, which required 21.5 min of centrifugation and approximately 15 min of Ficoll-specific handling for gradient preparation, interphase collection, dilution, and transfers. The manuscript has also been revised to describe the gradient-free workflow as reducing Ficoll-specific processing rather than simply being faster or less time-consuming overall.
|
||||||||||||||||||||||||||||||||||||||||||||
|
Comments 3: Manual islet selection is inherently operator-dependent and may introduce greater person-to-person variability than a standardized density-gradient procedure. The authors should clarify whether isolations were performed by a single operator or multiple operators and, if only one operator was involved, discuss the lack of inter-operator validation as an important limitation of the claimed reproducibility. |
||||||||||||||||||||||||||||||||||||||||||||
|
Response 3: We agree that manual islet selection introduces an operator-dependent component into the workflow. All isolations and stereomicroscope-guided selection procedures in this study were performed by a single trained operator with experience in cell isolation. This minimized operator-related variability within the present study but did not allow us to assess inter-operator reproducibility. We have clarified this point in the manuscript and added a discussion of operator dependence, potential selection bias and the importance of standardized training and predefined selection criteria.
|
||||||||||||||||||||||||||||||||||||||||||||
|
Comments 4: Relatedly, manual selection may introduce selection bias because operators may preferentially recover larger, more intact, or more easily recognizable islets while excluding less obvious or partially disrupted islets. This could influence islet yield, cell-type composition, and downstream transcriptomic profiles, and the authors should discuss how manual selection criteria were standardized and whether any objective criteria were used. |
||||||||||||||||||||||||||||||||||||||||||||
|
Response 4: We agree that manual selection can introduce selection bias, particularly if operators preferentially collect large or morphologically intact islets. We have therefore clarified the selection procedure in the Materials and Methods. No predefined size cutoff was used, and all visually identifiable islets were considered for collection, including small, medium, large, elongated, and partially disrupted islets when present. Islets associated with acinar tissue were gently pipetted to remove surrounding exocrine tissue and were excluded only if they could not be sufficiently separated. The dish was also periodically redistributed and re-examined to reduce the likelihood of overlooking small or initially obscured islets. These criteria were applied consistently throughout all isolations. No quantitative morphometric or automated image-based criteria were used, and this is now stated explicitly. Figure 4C and its legend were also revised to illustrate representative islets of different sizes and morphologies, including islets associated with residual acinar tissue. The potential for residual operator-dependent selection bias is additionally acknowledged in the Discussion.
|
||||||||||||||||||||||||||||||||||||||||||||
|
Comments 5: The interpretation that the gradient-free procedure may reduce processing-associated cellular stress should be substantially tempered. Manual microscopic selection, repeated aspiration and transfer, prolonged handling, and time outside optimal physiological conditions may themselves induce mechanical or transcriptional stress, so removal of Ficoll centrifugation cannot by itself be assumed to reduce total cellular stress. |
||||||||||||||||||||||||||||||||||||||||||||
|
Response 5: We agree with the reviewer that omission of Ficoll-based purification cannot by itself be interpreted as evidence of reduced overall processing-associated cellular stress. We have therefore substantially tempered the interpretation of the stress-response data throughout the manuscript. In the Introduction, we removed the suggestion that the workflow was designed to reduce cellular stress and now describe its objective in terms of omitting Ficoll-specific centrifugation, washing, and transfer steps. In the Abstract and Results, differences in stress-response scores and immediate early gene expression are now presented as descriptive observations between the two pooled libraries. We also explicitly state in the Results that only one pooled scRNA-seq library was generated for each workflow and that all stress-related comparisons are descriptive.
|
||||||||||||||||||||||||||||||||||||||||||||
|
Comments 6: The stress-response comparison is particularly limited because the three independently isolated mice were pooled to generate only one scRNA-seq library for each workflow. The authors appropriately acknowledge that these libraries represent single experimental units and that the observed differences cannot be attributed to the isolation method; therefore, statements in the Abstract, Results, and Discussion suggesting reduced stress with the gradient-free protocol should consistently be presented as descriptive observations rather than evidence of a method-specific effect. |
||||||||||||||||||||||||||||||||||||||||||||
|
Response 6: We agree that the stress-response comparison should be interpreted cautiously because only one pooled scRNA-seq library was generated for each workflow. We revised the Abstract, Results, Discussion, and Conclusions to present all stress-related differences as descriptive observations rather than method-specific effects. We also clarified that manual selection and ex vivohandling may themselves contribute to stress and that independent matched libraries are required to determine whether the gradient-free workflow reproducibly affects cell recovery, cellular composition, or processing-associated transcriptional responses.
|
||||||||||||||||||||||||||||||||||||||||||||
|
Comments 7: The Introduction may benefit from briefly acknowledging the broader relevance of pancreatic molecular alterations and emerging molecular biomarkers. In this context, the authors may consider citing the recent review https://doi.org/10.3389/freae.2025.1723159, which provides a useful overview of molecular and epigenetic changes in pancreatic disease and their translational relevance. |
||||||||||||||||||||||||||||||||||||||||||||
|
Response 7: We thank the reviewer for this suggestion. We have expanded the Introduction to briefly acknowledge the broader relevance of molecular and epigenetic alterations in pancreatic disease and their potential value as diagnostic, prognostic, and predictive biomarkers. The recommended recent review has been cited in this context. We also linked this broader molecular perspective to the importance of standardized sample procurement and processing for reproducible downstream molecular analyses.
|
||||||||||||||||||||||||||||||||||||||||||||
|
Comments 8: Because density-gradient purification is a well-established and relatively standardized method, the practical value of replacing it with manual selection would be strengthened by a more comprehensive comparison of the two approaches. In addition to viability and scRNA-seq QC, useful parameters would include total processing time, hands-on time, islet yield, purity, operator-to-operator variability, and reproducibility across independent scRNA-seq libraries; without such comparisons, the gradient-free approach is best presented as a feasible alternative rather than an improved replacement for density-gradient purification. |
||||||||||||||||||||||||||||||||||||||||||||
|
Response 8: We agree that a broader comparison would be required to establish the gradient-free workflow as an improved replacement for density-gradient purification. We have therefore revised the manuscript to present it consistently as a feasible alternative. A side-by-side comparison of processing time has been added (Table 2), and the manuscript now discusses viable cell recovery, viability, scRNA-seq QC, operator dependence, and the limitations of manual selection. We also explicitly acknowledge that islet yield per pancreas, pre-dissociation purity, inter-operator variability, and reproducibility across independently prepared scRNA-seq libraries were not assessed. These parameters are now identified as priorities for future comparative validation.
We have added a side-by-side comparison of the processing times for the gradient-free and Ficoll-based workflows |
||||||||||||||||||||||||||||||||||||||||||||
Author Response File:
Author Response.pdf
Round 2
Reviewer 1 Report
Comments and Suggestions for AuthorsMost of my previous comments have been addressed. I have two remaining points:
- Please check the description of the time saved by omitting Ficoll purification. Table 4 shows that the Ficoll step takes about 35 min in total, including 21.5 min of centrifugation and about 15 min of Ficoll-specific handling. Therefore, statements referring to “35 min less centrifuge run time” are not accurate. Please revise these statements throughout the manuscript. It would be more accurate to state that the gradient-free workflow shortens the overall processing time by about 35 min, including 21.5 min of centrifugation.
- The cell numbers in Table 2 appear to be assigned to the wrong workflows. The text reports 5,568 initially identified cells and 2,659 final cells for the gradient-free library, and 4,358 and 2,715 cells for the Ficoll-based library, whereas Table 2 shows the reverse. Please correct Table 2 accordingly.
Author Response
|
Response to Reviewer 1 Comments |
|||||||||||||||||
|
1. Summary |
|
|
|||||||||||||||
|
We are very grateful for the thoughtful and constructive feedback, which helped us improve the manuscript. We have addressed all comments carefully, and the corresponding revisions are highlighted in the updated version. We have also updated the Data Availability Statement to include the newly assigned GEO accession number, GSE347182 (Line 666). Our point-by-point responses are provided below. |
|||||||||||||||||
|
2. Questions for General Evaluation |
Reviewer’s Evaluation |
Response and Revisions |
|||||||||||||||
|
Does the introduction provide sufficient background and include all relevant references? |
Yes/Can be improved/Must be improved/Not applicable |
|
|||||||||||||||
|
Are all the cited references relevant to the research? |
Yes/Can be improved/Must be improved/Not applicable |
|
|||||||||||||||
|
Is the research design appropriate? |
Yes/Can be improved/Must be improved/Not applicable |
|
|||||||||||||||
|
Are the methods adequately described? |
Yes/Can be improved/Must be improved/Not applicable |
|
|||||||||||||||
|
Are the results clearly presented? |
Yes/Can be improved/Must be improved/Not applicable |
|
|||||||||||||||
|
Are the conclusions supported by the results? |
Yes/Can be improved/Must be improved/Not applicable |
|
|||||||||||||||
|
3. Point-by-point response to Comments and Suggestions for Authors |
|||||||||||||||||
|
Comments 1: Please check the description of the time saved by omitting Ficoll purification. Table 4 shows that the Ficoll step takes about 35 min in total, including 21.5 min of centrifugation and about 15 min of Ficoll-specific handling. Therefore, statements referring to “35 min less centrifuge run time” are not accurate. Please revise these statements throughout the manuscript. It would be more accurate to state that the gradient-free workflow shortens the overall processing time by about 35 min, including 21.5 min of centrifugation. |
|||||||||||||||||
|
Response 1: We appreciate this careful observation. We agree that the previous wording incorrectly described the approximately 35-min difference as centrifuge run time. Table 4 shows that the Ficoll-specific purification module required approximately 35 min in total, comprising 21.5 min of centrifugation and approximately 15 min of additional handling. We have therefore revised the corresponding statements throughout the Introduction, Results, Discussion, and Conclusions to state that omission of Ficoll purification shortened the estimated overall processing time by approximately 35 min, including 21.5 min of centrifugation.
|
|||||||||||||||||
|
Comments 2: The cell numbers in Table 2 appear to be assigned to the wrong workflows. The text reports 5,568 initially identified cells and 2,659 final cells for the gradient-free library, and 4,358 and 2,715 cells for the Ficoll-based library, whereas Table 2 shows the reverse. Please correct Table 2 accordingly. |
|||||||||||||||||
|
|
|||||||||||||||||
Author Response File:
Author Response.pdf